Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics, a leader in cell therapy, has announced a ...

Chimeric RNAs and the proteins translated from them often have a causal role in tumorigenesis. They are also occasionally found at low levels in healthy cells. These phenomena were previously ...

在肿瘤治疗领域，嵌合抗原受体（CAR，Chimeric antigen receptor）-T（即 CAR-T）细胞疗法作为一种革命性的免疫治疗方法，已经在血液肿瘤治疗中取得了显著成效。过去几年，美国食品药品监督管理局（FDA，Food and ...

European patients had previously seen an improvement in their lupus symptoms after the therapy was tested in an earlier trial ...

*仅供医学专业人士阅读参考APOE4是阿尔茨海默病（AD）的最强遗传风险因素，降低AD发病年龄，促进AD的典型病理，包括β-淀粉样蛋白（Aβ）和过度磷酸化的tau蛋白（p-tau）沉积。APOE4在AD发病机制中的作用十分复杂，仍没有被完全揭示。星形 ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics made significant strides in its cell therapy programs, enrolling the first patient in its CHM CDH17 Phase 1/2 ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics Ltd. has announced the issuance of nearly 70 million fully paid ordinary shares for quotation on the Australian ...

SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This ...

《中时新闻网》前身为《中时电子报》，于1995年创立，是全台第一家且歷史最悠久的网路媒体，开启新闻数位时代。近来以最具影响力的政治新闻引领先驱外，首创娱乐、生活、社会专题式新闻报导，带起同业间仿效风潮；精辟的言论、财经、国际、两岸、军事、体育、网推频道，网罗忠实读者群；新型态的汽车、房屋、玩食、科技频道，成为阅听眾休閒必看选择。视觉影音上，结合中天新闻直播、FB直播、中时新闻网APP等平台的精彩内 ...

A recent meta-analysis investigating cardiovascular complications in adults undergoing chimeric antigen receptor (CAR) T-cell ...

About Hemogenyx Pharmaceuticals plc Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and ...